From Reuters.

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer medicines posted double-digit growth, lifting the British drugmaker’s shares.

#News #Reuters #Newsfeed #gsk #cancer #medicine

Read the story here: https://reut.rs/49b0zBx

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en